Перевести на Переведено сервисом «Яндекс.Перевод»

ZIOPHARM Oncology

Country
USA
Краткое название
ZIOPHARM Oncology
Headquarters
1180 Avenue of the Americas Suite 2020 New York, NY 10036
Members of the board

Jonathan J. Lewis M.D., Ph.D.,
Chief Executive Officer, Director
Jason A. Amello,
Chief Financial Officer, Executive Vice President
Hagop Youssoufian M.D,.
President of Research and Development and Chief Medical Officer
Caesar J. Belbel,
Executive Vice President, Chief Legal Officer, Secretary
Murray Brennan M.D.,
Non-Executive Lead Independent Director
Randal J. Kirk,
Director
James A. Cannon,
Independent Director
Wyche Fowler Jr., J.D.,
Independent Director
Timothy McInerney,
Independent Director

Categories medicine
Oncology
Stage of the project
Production
Disease
Blood cancer, Thyroid and vascular gland cancer, Virilia cancer, Muliebria cancer, Breast cancer, Lung cancer, Intestine cancer, Gastric cancer
Ticker
ZIOP
Current owners

Murray Brennan, M.D. (Lead Director)
James A. Cannon,
Chief Financial Officer and Vice Chairman, BBDO
Senator Wyche Fowler, Jr.,
Former U.S. Senator and Ambassador to Saudi Arabia
Randal J. Kirk,
Chief Executive Officer and Chairman of the Board, Intrexon Corporation
Jonathan Lewis, M.D., Ph.D.,
Chief Executive Officer
ZIOPHARM Oncology, Inc.
Timothy McInerney,
Partner, Riverbank Capital Securities Inc.
Michael Weiser, M.D., Ph.D.,
Partner, Actin Biomed

Assets
1.5100
Technology
Cell Technologies, Devices, Technologies, Pharmaceuticals, Chemistry